FOXO TECHNOLOGIES INC.

FOXOW ·Healthcare, Diagnostics & Research, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021
Revenue $16.4M $4.1M $145.3K $511.0K $120.0K
Cost of Revenue $132.0K $344.0K $120.0K
Gross Profit $13.0K $167.0K $120.0K
Gross Margin 8.9% 32.7% 100.0%
Operating Expenses
Research & Development $182.5K $312.3K $900.4K $3.0M $4.9M
SG&A Expense $11.4M $7.2M $19.4M $25.8M $10.3M
Operating Income $-10.3M $-7.8M $-22.2M $-40.2M $-15.0M
Operating Margin -63.1% -191.6% -15,271.2% -7,860.5% -12,525.8%
Interest Expense $3.4M $3.9M $1.1M $1.4M $1.1M
Pretax Income $-12.6M $-12.4M $-26.5M
Income Tax Expense $-182.8K
Net Income $-12.4M $-12.4M $-26.5M $-95.3M $-38.5M
Net Margin -75.9% -306.2% -18,205.2% -18,640.9% -32,073.3%
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Basic) 3.73B 35.8M 10.7M 29.6M
Shares Outstanding (Diluted) 3.73B 35.8M 10.7M 29.6M
Dividends Per Share